1. Home
  2. GLU vs ACOG Comparison

GLU vs ACOG Comparison

Compare GLU & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gabelli Global Utility of Beneficial Ownership

GLU

Gabelli Global Utility of Beneficial Ownership

HOLD

Current Price

$19.83

Market Cap

119.3M

Sector

Finance

ML Signal

HOLD

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

HOLD

Current Price

$5.77

Market Cap

115.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLU
ACOG
Founded
2004
2000
Country
United States
Canada
Employees
N/A
N/A
Industry
Finance/Investors Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
119.3M
115.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GLU
ACOG
Price
$19.83
$5.77
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$18.00
AVG Volume (30 Days)
12.4K
82.9K
Earning Date
01-01-0001
11-13-2025
Dividend Yield
8.60%
N/A
EPS Growth
N/A
N/A
EPS
0.62
N/A
Revenue
N/A
$7,427,199.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$132.35
P/E Ratio
$22.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.61
$3.75
52 Week High
$15.40
$11.54

Technical Indicators

Market Signals
Indicator
GLU
ACOG
Relative Strength Index (RSI) 61.28 42.02
Support Level $19.43 $6.11
Resistance Level $20.00 $6.62
Average True Range (ATR) 0.33 0.41
MACD 0.01 -0.06
Stochastic Oscillator 57.90 5.58

Price Performance

Historical Comparison
GLU
ACOG

About GLU Gabelli Global Utility of Beneficial Ownership

Gabelli Global Utility & Income Trust is a non-diversified, closed-end management investment company. The Fund's objective is to seek a consistent level of after-tax total return. It predominantly invests in stocks of companies involved to a substantial extent in providing products, services, or equipment for the generation or distribution of electricity, gas, or water and infrastructure operations, and in equity securities including preferred securities of companies in other industries, in each case in such securities that are expected to pay periodic dividends.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: